| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | 0.1 | 0.07 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.08 | 0.08 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.08 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.08 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.08 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.08 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.063 | 0.08 |